| Makale Türü |
|
||
| Dergi Adı | Rsc Advances (Q2) | ||
| Dergi ISSN | 2046-2069 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 02-2026 |
| Cilt / Sayı / Sayfa | 16 / 10 / 8807–8827 | DOI | 10.1039/d5ra10080a |
| Makale Linki | https://doi.org/10.1039/d5ra10080a | ||
| UAK Araştırma Alanları |
Enzim ve Mikrobiyal Biyoteknoloji
Biyoteknoloji
Moleküler Biyoloji
|
||
| Özet |
| Alzheimer's disease seems to be the result of several tumultuous processes such as cholinergic deficits associated with the abnormal metabolic status and oxidative stress that cannot be controlled effectively by single-target molecules. A complex group of agents capable of combining specific enzyme inhibition with antioxidant protection may be seen as an approach toward neuroprotection. The partial synthesis method led to the creation of a new series of chromone hydrazones (3a–p) from substituted hydrazones and 6-hydroxy-chromone. All the newly obtained hydrazones were assayed for their inhibitory activity against acetylcholinesterase (AchE) and human carbonic anhydrases (CA I and II), and their antioxidant potentials were also studied. The chromone-substituted hydrazones 3c, 3e, and 3f exhibited good inhibitory activity against AChE with IC50 values of 0.82 µM, 0.20 µM, and 1.11 µM, respectively … |
| Anahtar Kelimeler |
| Atıf Sayıları | |
| Web of Science | 3 |
| Scopus | 3 |
| Google Scholar | 3 |
| Dergi Adı | RSC Advances |
| Yayıncı | Royal Society of Chemistry |
| Açık Erişim | Evet |
| E-ISSN | 2046-2069 |
| CiteScore | 7,6 |
| SJR | 0,777 |
| SNIP | 0,964 |